Sg Americas Securities, LLC Cassava Sciences Inc Transaction History

Sg Americas Securities, LLC

$24.4 Billion
Q4 2024

A detailed history of Sg Americas Securities, LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Sg Americas Securities, LLC holds 12,387 shares of SAVA stock, worth $21,057. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,387

Previous 17,475 29.12%

Holding current value

$21,057

Previous $514,000 94.36%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	SELL	$2.29 - $32.18 $11,651 - $163,731	-5,088 Reduced 29.12%	12,387 $29,000
Q3 2024 Oct 03, 2024	BUY	$9.57 - $35.08 $167,235 - $613,023	17,475 New	17,475 $514,000
Q4 2023 Jan 12, 2024	SELL	$12.64 - $30.11 $2.33 Million - $5.54 Million	-184,073 Reduced 66.59%	92,359 $2.08 Million
Q3 2023 Oct 13, 2023	BUY	$16.64 - $25.32 $2.14 Million - $3.26 Million	128,770 Added 87.21%	276,432 $4.6 Million
Q2 2023 Jul 10, 2023	SELL	$21.59 - $27.88 $680,667 - $878,972	-31,527 Reduced 17.59%	147,662 $3.62 Million
Q1 2023 Apr 28, 2023	BUY	$23.46 - $36.44 $3.37 Million - $5.24 Million	143,752 Added 405.66%	179,189 $4.32 Million
Q4 2022 Feb 02, 2023	BUY	$27.82 - $44.16 $842,862 - $1.34 Million	30,297 Added 589.44%	35,437 $1.05 Million
Q3 2022 Oct 31, 2022	SELL	$16.33 - $51.06 $757,009 - $2.37 Million	-46,357 Reduced 90.02%	5,140 $215,000
Q2 2022 Jul 29, 2022	BUY	$17.22 - $38.47 $776,346 - $1.73 Million	45,084 Added 703.01%	51,497 $1.45 Million
Q1 2022 Apr 29, 2022	BUY	$32.6 - $53.05 $25,558 - $41,591	784 Added 13.93%	6,413 $238,000
Q4 2021 Feb 07, 2022	SELL	$36.77 - $90.91 $5.05 Million - $12.5 Million	-137,259 Reduced 96.06%	5,629 $246,000
Q3 2021 Nov 01, 2021	BUY	$41.79 - $135.3 $5.9 Million - $19.1 Million	141,251 Added 8628.65%	142,888 $8.87 Million
Q2 2021 Aug 12, 2021	SELL	$32.15 - $89.72 $115,161 - $321,377	-3,582 Reduced 68.63%	1,637 $140,000
Q1 2021 May 13, 2021	BUY	$7.09 - $87.95 $37,002 - $459,011	5,219 New	5,219 $235,000
Q3 2020 Nov 09, 2020	SELL	$2.86 - $11.51 $35,967 - $144,749	-12,576 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$2.04 - $9.64 $25,655 - $121,232	12,576 New	12,576 $39,000

Others Institutions Holding SAVA

# of Institutions

190

Shares Held

16.4M

Call Options Held

3.49M

Put Options Held

8.08M

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $68.2M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Cassava Sciences Inc Transaction History